Exclusive-Novo’s Wegovy and Ozempic US Advertising Spend Doubles Rival Eli Lilly, Data Shows
By Harshita Mary Varghese and Patrick WingroveJan 28 (Reuters) – Novo Nordisk spent nearly $500 million on U.S. advertising for its GLP-1 drugs…
Why I’m so excited about the weight loss drugs I’ll never take
Last year, for the first time, food consumption went down, reported the Financial Times, making 2025 “the first year on record where the volume of food consumed in America has decreased.” The weight loss drugs are taking their pound of flesh: not just from their own delighted customers, but from the food industry too. Meanwhile, this week […]
Lawsuits raise new safety questions about GLP-1 drugs | The Excerpt
GLP-1 drugs like Ozempic and Wegovy are everywhere — but thousands of users now allege the medications caused severe, life-altering injuries including everything from stomach paralysis and colon ruptures to sudden blindness. Drugmakers deny the allegations and say the medications are safe when used as directed. USA TODAY investigative data reporter Austin Fast explains what […]
Taking Ozempic Won’t Help Weight Loss, Daily Exercise Matters: New Study
A new randomized trial shows that GLP-1 weight-loss drugs like liraglutide help reduce weight but don’t improve physical fitness on their own. Structured exercise is essential for meaningful…
41 People Who Got Plastic Surgery And Now Look Like A Whole New Version Of Themselves
Imagine hopping in a time machine, going back a century, and telling someone that today, if you have the money for it, you can walk into a clinic and come out with a new nose or a face that looks twenty years younger. They’d think you lost your mind. But here we are—plastic surgery is […]
Hanmi Secures Export Deal with Mexican Partner Sanfer for GLP-1 Obesity Drug and More
Hanmi Signs Exclusive Partnership with New Mexican Partner Laboratorios Sanfer, Covering Efpeglenatide and Diabetes Treatments SEOUL, South Korea, Jan. 27, 2026 /PRNewswire/ — Hanmi is accelerating its global market entry with efpeglenatide, Korea’s first domestically developed GLP-1…
I built a global GLP-1 telehealth directory (and why it’s harder than it looks)
GLP-1 medications (like semaglutide and tirzepatide) have exploded in demand, but finding legitimate, accessible telehealth providers is still surprisingly hard — especially outside the US. So I built GLP-1 Patches, a global directory of GLP-1 telehealth providers. What problem I was trying to solve Most existing resources are: US-only SEO farms or affiliate-heavy Opaque about […]
Trump administration announces 15 new drugs for Medicare price negotiation program
By ALI SWENSON NEW YORK (AP) — Drugs that treat Type 2 diabetes, HIV and arthritis are among 15 new medications chosen for a Medicare drug price negotiation program that allows the federal government to haggle directly with drug manufacturers, the Trump administration said Tuesday. Related Articles DeSantis administration sends investigators to probe marijuana referendum […]
Effects of Liraglutide on Gut Bacterial Community Dynamics
Liraglutide, a GLP-1 receptor agonist, is used to induce weight loss. However, limited information exists on liraglutides effects on the gut bacterial community and their restoration after washout. We investigated liraglutides effect on the gut bacterial community in diet-induced obese (DIO) mice and whether these changes persist after washout. Twenty-four male C57BL/6J mice on high-fat […]
CMS picks Lilly’s Trulicity for third round of Medicare negotiations
Another GLP-1 drug is up for Medicare negotiations under the Inflation Reduction Act. Eli Lilly’s diabetes drug Trulicity is among 15 drugs selected for the third round of negotiations. For the …